Department of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
JMIR Public Health Surveill. 2021 Dec 23;7(12):e30424. doi: 10.2196/30424.
There are concerns that vaccine hesitancy may impede COVID-19 vaccine rollout and prevent the achievement of herd immunity. Vaccine hesitancy is a delay in acceptance or refusal of vaccines despite their availability.
We aimed to identify which people are more and less likely to take a COVID-19 vaccine and factors associated with vaccine hesitancy to inform public health messaging.
A Canadian cross-sectional survey was conducted in Canada in October and November 2020, prior to the regulatory approval of the COVID-19 vaccines. Vaccine hesitancy was measured by respondents answering the question "what would you do if a COVID-19 vaccine were available to you?" Negative binomial regression was used to identify the factors associated with vaccine hesitancy. Cluster analysis was performed to identify distinct clusters based on intention to take a COVID-19 vaccine, beliefs about COVID-19 and COVID-19 vaccines, and adherence to nonpharmaceutical interventions.
Of 4498 participants, 2876 (63.9%) reported COVID-19 vaccine hesitancy. Vaccine hesitancy was significantly associated with (1) younger age (18-39 years), (2) lower education, and (3) non-Liberal political leaning. Participants that reported vaccine hesitancy were less likely to believe that a COVID-19 vaccine would end the pandemic or that the benefits of a COVID-19 vaccine outweighed the risks. Individuals with vaccine hesitancy had higher prevalence of being concerned about vaccine side effects, lower prevalence of being influenced by peers or health care professionals, and lower prevalence of trust in government institutions.
These findings can be used to inform targeted public health messaging to combat vaccine hesitancy as COVID-19 vaccine administration continues. Messaging related to preventing COVID among friends and family, highlighting the benefits, emphasizing safety and efficacy of COVID-19 vaccination, and ensuring that health care workers are knowledgeable and supported in their vaccination counselling may be effective for vaccine-hesitant populations.
人们担心疫苗犹豫可能会阻碍 COVID-19 疫苗的推出,并阻止群体免疫的实现。疫苗犹豫是指尽管疫苗可用,但人们还是会延迟接受或拒绝疫苗。
我们旨在确定哪些人更有可能或更不可能接种 COVID-19 疫苗,并确定与疫苗犹豫相关的因素,以为公共卫生信息传递提供依据。
在 2020 年 10 月至 11 月,在 COVID-19 疫苗获得监管批准之前,在加拿大进行了一项加拿大横断面调查。通过回答“如果有 COVID-19 疫苗可供您使用,您会怎么做?”来衡量疫苗犹豫。使用负二项回归来确定与疫苗犹豫相关的因素。基于接种 COVID-19 疫苗的意愿、对 COVID-19 和 COVID-19 疫苗的信念以及对非药物干预措施的依从性,进行聚类分析以确定不同的聚类。
在 4498 名参与者中,有 2876 名(63.9%)报告存在 COVID-19 疫苗犹豫。疫苗犹豫与(1)较年轻的年龄(18-39 岁),(2)较低的教育程度和(3)非自由党派政治倾向显著相关。报告疫苗犹豫的参与者不太可能认为 COVID-19 疫苗将结束大流行,或者 COVID-19 疫苗的好处大于风险。有疫苗犹豫的人更担心疫苗的副作用,更不容易受到同龄人和医疗保健专业人员的影响,并且对政府机构的信任度较低。
这些发现可用于为对抗 COVID-19 疫苗接种犹豫提供有针对性的公共卫生信息传递,因为 COVID-19 疫苗接种工作仍在继续。与预防朋友和家人中的 COVID 相关的信息传递,强调 COVID-19 疫苗接种的益处,强调安全性和有效性,以及确保医疗保健工作者在接种咨询方面知识渊博并得到支持,可能对疫苗犹豫人群有效。